Latest Regulatory Milestones News

Beacon Minerals has secured critical regulatory approvals for the Iguana Deposit, setting the stage for mining operations and a comprehensive five-year resource development strategy.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.

Genesis Minerals has secured regulatory approval for Stage One mining at Tower Hill, aligning the project with its mill expansion plans and setting the stage for production in FY28.

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.

Imagion Biosystems has reached key milestones in its MagSense® HER2 breast cancer imaging program, including starting manufacturing for its Phase 2 trial and launching an AI imaging protocol collaboration with Wayne State University.

Boab Metals has extended its option to acquire full ownership of the Sorby Hills Project to the end of 2025, while locking in critical commercial agreements and environmental approvals that pave the way for a final investment decision.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Delorean Corporation has locked in a long-term biomethane supply agreement with Origin Energy, underpinning its SA1 Salisbury bioenergy project with up to $40 million in revenue over 10 years.

Magnetite Mines Limited’s MGTOF securities have been reinstated to ASX quotation following compliance with key listing rules, marking a significant regulatory milestone for the iron ore miner.

Diablo Resources has secured key drilling approvals for its Phoenix Copper Project in Utah, accelerating exploration in a critical US copper district. Early surface samples at the Fair Dinkum Prospect show promising copper and silver grades, setting the stage for a pivotal drilling campaign.

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.